Cargando…
JAC1 suppresses proliferation of breast cancer through the JWA/p38/SMURF1/HER2 signaling
The overexpression of HER2 is associated with a malignant proliferation of breast cancer. In this study, we developed a non-cytotoxic JWA gene activating compound 1 (JAC1) to inhibit the proliferation of HER2-positive breast cancer cells in vitro and in vivo experimental models. JAC1 increased the u...
Autores principales: | Ren, Yanlin, Chen, Dongyin, Zhai, Zurong, Chen, Junjie, Li, Aiping, Liang, Yan, Zhou, Jianwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055679/ https://www.ncbi.nlm.nih.gov/pubmed/33875644 http://dx.doi.org/10.1038/s41420-021-00426-y |
Ejemplares similares
-
JAC1 targets YY1 mediated JWA/p38 MAPK signaling to inhibit proliferation and induce apoptosis in TNBC
por: Zhai, Zurong, et al.
Publicado: (2022) -
JAC4 Protects from X-ray Radiation-Induced Intestinal Injury by JWA-Mediated Anti-Oxidation/Inflammation Signaling
por: Zhou, Yan, et al.
Publicado: (2022) -
JWA suppresses proliferation in trastuzumab-resistant breast cancer by downregulating CDK12
por: Liang, Yan, et al.
Publicado: (2021) -
JAC4 Inhibits EGFR-Driven Lung Adenocarcinoma Growth and Metastasis through CTBP1-Mediated JWA/AMPK/NEDD4L/EGFR Axis
por: Ding, Kun, et al.
Publicado: (2023) -
Targeting JWA for Cancer Therapy: Functions, Mechanisms and Drug Discovery
por: Ding, Kun, et al.
Publicado: (2022)